The RÔMACIL brand, founded in 2014 (United States), from 167 sister brands and 2617 competing brands. RÔMACIL is owned by LONZA GRP, listed on the stock exchange of Zurich Its International Securities Identification Number (ISIN) is CH0013841017. The sector of RÔMACIL is Medical Diagnostics & Research.
Investment simulator :
Portfolio valuation
LONZA GRP
(RÔMACIL)
over 5 years*
CHF 939.45